Morgan Stanley’s Omega Protein OME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-52,179
| Closed | -$869K | – | 6808 |
|
|
2017
Q3 | $869K | Buy |
52,179
+15,817
| +43% | +$257K | ﹤0.01% | 4522 |
|
|
2017
Q2 | $651K | Sell |
36,362
-40,621
| -53% | -$759K | ﹤0.01% | 4640 |
|
|
2017
Q1 | $1.54M | Sell |
76,983
-15,465
| -17% | -$360K | ﹤0.01% | 4036 |
|
|
2016
Q4 | $2.32M | Buy |
92,448
+58,758
| +174% | +$1.39M | ﹤0.01% | 3806 |
|
|
2016
Q3 | $787K | Buy |
33,690
+11,263
| +50% | +$265K | ﹤0.01% | 4215 |
|
|
2016
Q2 | $448K | Sell |
22,427
-37,980
| -63% | -$709K | ﹤0.01% | 4496 |
|
|
2016
Q1 | $1.02M | Sell |
60,407
-99,229
| -62% | -$2.03M | ﹤0.01% | 3921 |
|
|
2015
Q4 | $3.54M | Buy |
159,636
+103,671
| +185% | +$2.16M | ﹤0.01% | 2992 |
|
|
2015
Q3 | $950K | Buy |
55,965
+12,647
| +29% | +$197K | ﹤0.01% | 4149 |
|
|
2015
Q2 | $595K | Sell |
43,318
-48,688
| -53% | -$647K | ﹤0.01% | 4593 |
|
|
2015
Q1 | $1.26M | Buy |
92,006
+14,645
| +19% | +$169K | ﹤0.01% | 3952 |
|
|
2014
Q4 | $818K | Sell |
77,361
-42,725
| -36% | -$506K | ﹤0.01% | 4313 |
|
|
2014
Q3 | $1.5M | Sell |
120,086
-31,243
| -21% | -$436K | ﹤0.01% | 3683 |
|
|
2014
Q2 | $2.07M | Buy |
151,329
+88,430
| +141% | +$1.16M | ﹤0.01% | 3456 |
|
|
2014
Q1 | $758K | Sell |
62,899
-21,851
| -26% | -$250K | ﹤0.01% | 4233 |
|
|
2013
Q4 | $1.04M | Sell |
84,750
-153,660
| -64% | -$1.8M | ﹤0.01% | 3908 |
|
|
2013
Q3 | $2.42M | Sell |
238,410
-74,997
| -24% | -$701K | ﹤0.01% | 3071 |
|
|
2013
Q2 | $2.81M | Buy |
+313,407
| New | +$3.16M | ﹤0.01% | 2862 |
|
Morgan Stanley's OME Position: Q4 2017 in Review
Morgan Stanley sold out of Omega Protein (OME) in Q4 2017, closing a stake of 52,179 shares — an estimated $869K sold.
Morgan Stanley first reported a position in OME in Q2 2013 and held it in 18 quarters. The position peaked at $3.54M in Q4 2015. 0 funds tracked by Wall St. Rank hold OME as of Q4 2017.
- Morgan Stanley reported no remaining Omega Protein position as of Q4 2017 after selling out during the quarter.
- Morgan Stanley sold 52,179 Omega Protein shares in Q4 2017, an estimated $869K.
- Morgan Stanley first reported a position in Omega Protein in Q2 2013 and held it in 18 quarters.
- Morgan Stanley's Omega Protein position peaked at $3.54M in Q4 2015.
- 0 funds tracked by Wall St. Rank held Omega Protein as of Q4 2017.
Based on Morgan Stanley's 13F filing for Q4 2017, filed 14 Feb 2018.